Modulation of mRNA stability by regulatory cis-acting AU-rich elements (ARE) and ARE binding proteins (AUBPs) is an important posttranscriptional mechanism of gene expression control. We previously demonstrated that the 3'-untranslated region of bcl-2 mRNA contains an ARE that accounts for rapid bcl-2 downregulation in response to apoptotic stimuli. We also demonstrated that the bcl-2 ARE core interacts with a number of AUBPs, one of which is AUF1/hnRNP D, known for its interaction with mRNA elements of others genes. In an attempt to search for other bcl-2 mRNA-binding proteins, we used the yeast RNA Three-Hybrid System assay (RNA THS) and identified a novel human protein that interacts with bcl-2 ARE. We refer to it as Tino. The predicted protein sequence of Tino reveals two N-terminal hnRNP K homology motifs (KH) for nucleic acid binding and a C-terminal RING domain, endowed with a putative E3 ubiquitin-protein ligase activity. In addition the novel protein is evolutionarily conserved; the two following orthologous proteins have been identified with protein-protein BLAST: PEM-3 of Ciona savignyi and MEX-3 of Caenorhabditis elegans. Upon binding, Tino destabilizes a chimeric reporter construct containing the bcl-2 ARE sequence, revealing a negative regulatory action on bcl-2 gene expression at the posttranscriptional level.
INTRODUCTION
The fate of mRNAs has recently emerged as an important point of regulation of gene expression. mRNA localization, stability and protein translation are closely controlled. In general, these mechanisms are based on the cooperation between cis-and trans-acting elements. Interactions among regulatory factors constitute the mRNP, an integrated dynamic platform for RNA-protein and protein-protein interactions acting on the cellular fate of each bound mRNA (1) . It is now clear that this fate is determined within the nucleus, where pre-mRNAs are "coated" by hnRNP proteins (heterogeneous nuclear RiboNuclear Proteins). Some of them are able to shuttle between the nucleus and the cytoplasm (nucleocytoplasmic shuttling): in this manner nuclear and cytoplasmic events of mRNA metabolism are interconnected (2) . mRNP particle assembly is so integral to gene expression control that it is functionally conceptualized as a posttranscriptional "operon" (3, 4) .
One of the more investigated class of cis-acting factors are the AU-rich elements (ARE). AREs are involved in mRNP assembly and they are responsible for mRNA half-life control (5) . AREs were initially found in the 3'UTR of the mRNAs of early response genes such as c-fos, c-myc, c-jun, which code for
EXPERIMENTAL PROCEDURES
RNA Three-Hybrid library screening assay -The yeast strain L40-coat (Mata, ura 3-52, leu2-3, 112, his3-200, trp1-1, ade2, LYS2::(LexA-op)-HIS3, LexA-MS2coat (TRP1)) and plasmids pIIIA/MS2-1, pIIIA/MS2-2, pIIIA/IRE-MS2 were gifts from Dr. M. Wickens (University of Wisconsin). The RNA expression vector that we chose for hybrid RNAs transcription was pIIIA/MS2-1. The human bcl-2 ARE cDNA, cloned into the SmaI site of the pIIIA/MS2-1, spans nucleotides 944 to 1050 of the human bcl-2 mRNA (GenBank TM accession number M14745). The resulting plasmid, pIIIA/MS2-B2ARE, was constructed as previously described (16) . A derivative of yeast L40-coat containing pIIIA/MS2-B2ARE, was transformed with a human placenta MATCHMAKER cDNA library (# HL4025AH, CLONTECH). Double transformants were plated on synthetic media lacking leucine and histidine. 3 mM 3-aminotriazole (Sigma Chemical Co.) was used to select for relatively high levels of HIS3 reporter gene activation. About 1.2 x 10 7 yeast transformants were screened. After a week, 1040 white colonies were picked up and assayed according to the described procedures for RNA THS (17) . The RNA-dependent false-positives clones were identified at the end of the screening by mating assay, using the yeast R40-coat derivative strain (Matα, ura 3-52, leu2-3, 112, his3-200, trp1-1, ade2, LYS2::(LexA-op)-HIS3, LexA-MS2coat (TRP1)) containing the unrelated RNA, 5'IRE-MS23', and the deletion mutant version of bcl-2 ARE, 5'MS2-B2∆ARE3', whose nonameric motif was deleted and as a positive control the 5'MS2-B2ARE3'.
The B2∆ARE cDNA sequence was deleted of the UUAUUUAU motif, ranging from nucleotides 1005 to Reverse Transcriptase (Promega) following the manufacturer's recommendation. The reverse transcribed product was amplified in a 50 µl volume containing 25 pmol of gene specific primers, 50 mM Tris-HCl pH 9.0, 1.5 mM MgCl 2 , 15 mM (NH 4 )SO 4 , 0.1% Triton X-100, 2.5% DMSO and 0.7 -1 units of DyNAzyme TM EXT DNA Polymerase (Finnzymes). PCR was performed for 34 cycles, with annealing at 59 °C, using Antibodies and Western blotting analysis -Rabbit polyclonal anti-pTino antibody was raised against three synthetic peptides from pTino. The peptides were the following: pep1, NH2-CKIKALRAKTNTYIK-COOH (aa 24-38); pep2, NH2-CKRIQQRTHTYIVTPGRDKE-COOH (aa 121-139); pep3, NH2-CKTPNQGRRPPTATA-COOH (aa 199-212). The peptides were synthesized at the PRIMM s.r.l. (Milan, Italy) synthesis facility using the solid-phase peptide synthesis method with Fmoc-chemistry and purified by reverse-phase HPLC. The amino-terminal amino acid for each peptide was coupled to the keyhole limpet hemocyanin (KLH) protein, then the three KLH coupled-peptides were injected into two rabbits and serum was collected after the second injection. The antisera were purified by affinity column chromatography using CNBr-Sepharose resin (Pharmacia) for each purification, aliquoted and kept at -20 °C until use. For total protein preparation and Western analysis, cells were collected, washed with icecold phosphate-buffered saline, and lysed with RIPA lysis buffer (100 µl/well; 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM PMSF, 1 mM EDTA, 5 µg/ml Aprotinin, 5 µg/ml Leupeptin, 1% Triton X-100, 1% Sodium deoxycholate, 0.1% SDS). For Western blotting, 25 µg of total proteins were separated on 12.5% Tino is a novel bcl-2 AU-rich element Binding Protein SDS-PAGE in 1X Tris-glycine-SDS running buffer (ICN Biomedical Inc.), transferred with the Trans-blot SD/Semi-Dry Transfer cell (Bio-Rad) onto nitrocellulose membranes (Schleicher & Schuell) in 25 mM Tris, 192 mM glycine, 20% methanol, and 0.1% SDS at 0.330 A for 30 min in cold room. Membranes were blocked with 5% skim milk in PBS-T at RT for 1 hr prior to addition of rabbit polyclonal anti-pTino antibody (1:1,000), diluted in PBS-T overnight at 4 °C, or mouse monoclonal anti-His(C-term) antibody (Invitrogen, #R930-25) (1:5,000), diluted in PBS-T with 5% skim milk overnight at 4 °C. After washing, membranes were incubated with peroxidase-conjugated secondary antibodies for 1 hr at RT (1:10,000, rabbit, Amersham Biosciences; 1:5,000, goat, Sigma Chemical Co.) and washed again prior to detection with ECL Plus reagents on ECL Hyperfilm (Amersham Biosciences).
In Vitro Translation -The ORF fragment of Tino gene was PCR-amplified from plasmid pQETriSystem/Tino using the following primers: the forward primer 5'-GTTAATACGACTCACTATAGGGAAATAATAGTCAACATGACCGAGTGCGT-3', containing the T7 promoter sequence (un reverse primer 5'-CACTTAGTGATGGTGATGGTGATGGTGGTGCTCGA-3', containing the nucleotide sequence for the 8 histidine stretch present in the DNA template. The PCR product was incubated with the TNT-coupled transcription-translation reticulocyte lysate (Promega) in the presence of cold methionine, according to the manufacturer's instructions.
Gel Electrophoresis Mobility Shift Assay (GEMSA) -Mobility-shift assays were performed using a radiolabeled 107-nucleotide long RNA corresponding to the human bcl-2 mRNA located in the 3'UTR from nucleotide 944-1050 (GenBank TM accession number M14745) as described in Lapucci et al. (16) .
Increasing volumes of reticulocyte lysate product were incubated for 20 min at RT with 2 fmol (2 x 10 4 cpm/fmol) of 32 P-labeled bcl-2 ARE riboprobe in the presence of 10 mM Tris (pH 7.5), 100 mM KOAc, (18) , and pBS∆β (19) , containing the rabbit β-globin cDNA, were linearized with DdeI and NcoI enzymes respectively, and used for in vitro run-off transcriptions to produce specific antisense-riboprobes. 10 fmol of 32 P-labeled riboprobes were generated using T7 (pGAPM) and T3 (pBS∆β) RNA polymerases in the presence of [α-32 P]-UTP (800 Ci/mmol; Amersham Biosciences) according to the manufacturer's instructions for the MaxiScript Kit (Ambion). Riboprobes were synthesized to yield transcripts with specific activities of 1-2 x 10 4 cpm/fmol, and they were added (10 fmol each) to the total RNA isolated according to the Direct Protect TM Lysate RPA Kit (Ambion). Protected RNA fragments were fractionated by denaturing gel electrophoresis, dried and analysed using a Cyclone TM Storage Phosphor System (Packard). The GAPDH bands intensities were used to normalize β-globin bands to correct for loading errors. RNA half-lives and first-order decay constants were calculate from plots of percent of remaining RNA versus time using Prism 3.03 (GraphPad Software).
Tino is a novel bcl-2 AU-rich element Binding Protein a novel protein as determined using nucleotide-nucleotide BLAST. Consequently, the presence of a previously uncharacterised human gene was revealed which we named Tino (Fig. 1) .
RESULTS

Cloning
A second independent RNA Three-Hybrid library screening assay with a modified and improved version of the RNA THS was applied (unpublished results). Also with this modified RNA THS, p40 AUF1
and Tino were recovered; in particular the same IST of the novel gene was cloned. The LacZ reporter gene assay indicated that Tino protein (pTino) is the IST most specifically interacting with the bcl-2 ARE. Tino protein interacts in vitro with the 107mer ARE -In order to confirm the interaction of the novel protein with the 107mer sequence, a gel electrophoresis mobility shift assay (GEMSA) was performed.
The pTino was produced using the reticulocyte lysate system because of the difficulties producing recombinant protein either in bacteria or insect cells, probably due to its toxicity. Increasing amounts of in vitro synthesized Tino protein mix were incubated with the radioactively labelled 107mer ARE; efficient complex formation was observed with pTino, whose intensity parallels the volume of the protein synthesis mix (Fig. 2 ).
Tino and AUF1 proteins recognize different binding sites of the 107mer ARE -Using the RNA THS we
identified the site of the bcl-2 ARE bound by pTino. In agreement with the results of the binding specificity test performed with the mating assay, pTino recognizes the motifs possessing the nonamer region (B2ARE2, B2ARE3 and B2ARE7); importantly, the RNA-protein interaction is lost (B2ARE4) without the adenine stretch just upstream of this element (Fig 3A, 3B) . To determine the minimal motif bound by pTino, we tested B2ARE11 and B2ARE12 segments. We concluded that the 26 nt long sequence B2ARE11, containing both the adenine stretch and the nonamer, is the binding site of pTino (Fig 3A, 3B) .
In order to compare the binding profiles of pTino and AUF1 on the bcl-2 ARE, we have mapped the binding sites of p40 AUF1 (aa 94 -297), the other relevant protein found in the library screening, and p37 AUF1 (aa 1 -257), that recently we disclosed to be able to interact with the bcl-2 ARE in RNA THS (16) . p40 AUF1 is able to bind the segments within the first 75 nts of the bcl-2 ARE (B2ARE1, B2ARE2, B2ARE3, B2ARE5, B2ARE6 and B2ARE7), which identify a larger RNA recognition sequence (Fig 3A, Tino is a novel bcl-2 AU-rich element Binding Protein 3B). We determined that p40 AUF1 interacts independently with B2ARE10, B2ARE11 and the B2ARE12 motifs (Fig 3A, 3B) . p37 AUF1 recognizes the motifs B2ARE1, B2ARE2, B2ARE3 and B2ARE7, showing that its binding site is immediately upstream of the nonamer region. Accordingly, we found that p37 AUF1 is able to interact with B2ARE10 (Fig 3A, 3B) . We conclude that pTino and AUF1 isoforms display different, and partially overlapping, interaction profiles with the bcl-2 ARE.
Genomic structure and analysis of the human Tino gene -The cloned Tino cDNA contains 2,132 bp ( (Fig. 4C) . Moreover, an additional 40 amino acids from the KIAA2031 cDNA can be predicted at the N-terminus compared to pTino. KIAA2031 protein is probably a partial product since its initial amino acid is a proline and not a methionine.
A searching for homologous proteins recovered the putative ORF of the KIAA2009 sequence (GenBank TM accession number AB095929), whose locus lies on human chromosome 15q25.2 (Fig. 5) .
pTino may be a prototype of a protein family whose members are the KIAA2009 product and another putative member located on human chromosome 1q22. The latter is predicted because of the high identity score of local alignment obtained with our cDNA sequence and human EST sequences overlapping with that DNA region (GenBank TM accession numbers BE315075; BG746475; BQ947909).
No functionally characterized homologous sequences were obtained among other mammalian species, but Tino is a novel bcl-2 AU-rich element Binding Protein orthologous proteins exist, PEM-3 (Posterior End Mark-3) from Ciona Savignyi (22) and MEX-3 (Muscle EXcess-3) from C. Elegans (23) . These proteins possess the highest sequence identities concentrated at the level of the two KH domains for the nucleic acid binding, with PEM-3 sharing 74% identity and MEX-3 69% identity (Fig. 5) .
Expression and size determination of the Tino mRNA and protein -We examined the expression profile of endogenous Tino gene using human Northern blots containing poly(A) RNA from different healthy tissues (Fig. 6A) . A predominant ≈ 3.1 -3.2 kb transcript was detected, which was present at different levels in all the human tissues tested including heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. A putative splicing variant was also detected in heart and skeletal muscle tissues, with an apparent molecular size of ≈ 6.5 kb. These data indicate that most probably, Tino and KIAA2031 cDNA are related to partial transcripts. Also, the expression data from different human immortalized -RPE (retinal pigment epithelia) -and neoplastic cell lines -SH-SY5Y (neuroblastoma), K562 (chronic myelogenous leukemia), NB4 (acute promyelocytic leukemia), A431 (epidermoid carcinoma), HUVEC (primary human endothelial cells), HEK 293 (human embryonal kidney), HeLa (adenocarcinoma) and Jurkat T (acute T cell leukemia) -were obtained. Total RNA was extracted, reverse transcribed and amplified with gene specific primers. The specific band was detected in all the tested cell lines, with the exception of K562 cells where a very faint band was detectable (Fig. 6B) .
Ectopical expression of the Tino gene was examined by western blotting analysis. Total protein extracts from transiently transfected HeLa Tet-Off cells were collected and analyzed with the anti-pTino or the anti-His(C-term) antibody (Fig. 6C) . Following transfection of the Tino ORF with the pTRE2pur based vector, the recombinant protein was immunodetected (Fig. 6C, lane 4) . By contrast, no signal was detected in the total protein extract prepared from HeLa Tet-Off cells transfected with the empty vector (MOCK) (Fig. 6C, lane 3) . Recombinant pTino runs in SDS-PAGE with an apparent molecular mass of (Fig. 6C, lanes 2, 5) . By contrast, neither the His-tagged nor the untagged protein was detectable with the relative antibodies in the protein extract of the corresponding controls (MOCK) (Fig. 6C, lanes 1, 6) . The slight difference in molecular mass between the recombinant proteins expressed from the tetracycline-sensitive promoter or the constitutive promoter is due to the histidine stretch present in the recombinant protein produced by the second kind of vector. The probing of protein extracts with the anti-pTino antibody detects three others strong bands, two of which possess an apparent molecular weight of about 70-75 kDa and one of about 39 kDa. However, adsorption experiments with specific peptides allowed identification of an unspecific band (Fig. 6D) . overlap with the structure of our gene (data not shown). However, the N-terminal region of the predicted protein is 136 amino acids longer than KIAA2031; these additional amino acids correspond to a 408 bp exon, reaching a length of about 3,100 bp when added to the 2,441 bases of the KIAA2031 sequence and to the ≈ 200 bp of the poly(A) tail. Thus, to validate this prediction, we designed three forward primers within this region, and we used them for PCR amplification reactions starting from total RNA extracted from RPE and HeLa cells and reverse transcribed with random primers (Fig. 7A) . In both cell lines, the G2 forward primer alone, paired with the R1 reverse primer encompassing the first splice site junction of the gene, gave rise to PCR products. PCR amplicons can be obtained also with the G2-R2 primers (data not shown). On the other hand, no amplification products were obtained when G1-R1 and G3-R1 primer pairs were used. We focused on the G2-R1 major products, identified as two bands, that we gel purified and sequenced. The sequencing data demonstrate that the Tino cDNA was detected (Fig. 7B) . For each sequenced product, the relative sequence in the genomic context and the putative N-terminal region of Tino/KIAA2031 protein are shown. The major PCR product adds 77 bp to the 5' end of the KIAA2031 transcript. Also the human EST fs06d08.y1 (GenBank TM accession number CD674038) contains a 5' end similar to the Tino/KIAA2031 gene; indeed it is almost completely overlapping with this product, and the two sequences share 98% identity over the additional 77 bp. nucleoli. In addition, a spotted distribution of the protein is visible in the cytoplasm (Fig. 8A, 8B ). Nuclear staining faded away when anti-pTino antibody was preincubated with its peptide antigens. However the faint cytoplasmic staining remained (data not shown).
Localization of pTino -
pTino influences the levels of a β-globin/ARE chimeric transcript -We proceeded to study the function of (Fig. 9) . Upon transient transfection into HeLa Tet-Off cells, reporter mRNA synthesis was allowed for 48 hours until addition of doxycycline. RNA levels of reporter constructs were determined by RNase Protection Assay. Control β-globin mRNA lacking the ARE was intrinsically stable and Tino did not induce its decay, as observed during the 6 hour interval (Fig. 9, panel A, quantification in   panel C) . β-globin/ARE mRNA decays faster with an half-life of 6.3 hr. When Tino was cotransfected, the half-life of the chimeric RNA was reduced to 2.9 hr, indicating an enhanced decay rate (Fig. 9, panel B, quantification in panel C). We conclude that the bcl-2 ARE destabilizes the β-globin/ARE mRNA and ectopic expression of Tino acts through the bcl-2 ARE to enhance this effect. (Fig. 1) . In contrast, RNA-protein complex formation both in vivo and in vitro occurs with the wild-type bcl-2 ARE sequence ( Fig. 1, 2) . This indicates that the nonamer is needed for RNA-protein complex formation. However, the nonamer is not the only motif of bcl-2 ARE required for the interaction of pTino. We mapped the binding site of pTino and disclosed that it must also contain the adenine stretch immediately upstream of the nonamer (Fig. 3A,   3B ). Despite this relatively long sequence (5' -AGAAAAAAAGAUUUAUUUAUUUAAGA -3') is not shared with other ARE harbouring human mRNAs, we can not exclude the possibility that pTino could interact with other motifs.
Tino is a novel bcl-2 AU-rich element Binding Protein
The cloned cDNA is a 2,132 bp segment whose protein product has two K homology (KH) domains (Fig. 4A, 4C) . The conserved KH motif, first identified in human heterogeneous nuclear ribonucleoprotein K (hnRNP K), is shared by a wide variety of nucleic-acid binding proteins, many of which take part in the complex network of protein-protein and RNA-protein interactions regulating gene expression in eukaryotes (26) . KH domains consist of an α-β fold with a topology similar to that found in ribosomal proteins (27) . Like other RNA binding motifs, KH domains are found in either one or multiple copies; for This RING-finger is a specialized type of Zn 2+ -finger domain of 40 amino acids that bind two atoms of zinc, probably involved in mediating protein-protein interactions. Based on the cysteine/histidine pattern, the variant of RING module present in pTino is the C3HC4-type. The RING domain has been implicated in a range of biological processes. E3 ubiquitin protein ligase activity is ascribed to the RING domain of c-Cbl protein, which is able to recruit an E2 ubiquitin-conjugating enzyme and its own substrates (28) . It is believed that E3-like activity is a general function of the RING domain.
Evidence of the high degree of inter-species conservation of pTino is revealed from database searches using protein-protein BLAST (Fig. 5) . pTino is probably the prototype of a small protein family of KH-containing RNA binding proteins. Indeed, transcripts (KIAA2009) and EST sequences of unknown genes have been cloned and predicted to codify polypeptides similar to pTino, especially with respect to the KH domains. Two putative other members of the protein family can be found on human chromosomes 15q25.2 and 1q22. Among the ancient bilaterian animals, such as ascidians and nematodes, two orthologous proteins, PEM-3 (Ciona Savignyi) and MEX-3 (Caenorhabitis Elegans) respectively, have high homology with pTino (Fig. 5) . PEM-3 and MEX-3 proteins are RNA binding proteins whose biological relevance appears during embryonic development (22, 23) (32) . BCL-2 protein levels decrease along the myogenic pathway from muscle stem cell to myofiber. All these observations suggest that Tino may be a negative regulator of the bcl-2 gene during embryonic development.
MEX-3 acts in the cytoplasm during the early cleavage stages of the embryonic cell and is localized in P-granules (23) , which are cytoplasmic structures containing RNAs and RNA binding proteins playing a role in mRNA processing or packaging (33) . By contrast, we observed that endogenous protein is mostly distributed in the nuclear-perinuclear cell compartment (Fig. 8) .
Northern blot analysis of the transcript of Tino indicates an apparent size of about 3.1 Kb present in all tested poly(A) RNAs, extracted from human healthy tissues (Fig. 6A) . Placenta shows the stronger hybridization signal, while in the heart and skeletal tissue additional putative ≈ 6.5 Kb splicing variant is present. However, due to the low level of expression of this product, it can also be either a related transcript or a processing intermediate. The recently cloned KIAA2031 (20) cDNA is located in the same genetic locus as Tino on chromosome 19, suggesting that Tino and KIAA2031 are the same gene. Both sequences completely overlap except for two differences: the KIAA2031 transcript possesses a 187 nucleotide short intron containing the stop codon, which is not present in the Tino transcript. This raises the possibility that the two mRNAs are the result of the alternative splicing known as intron retention (34) .
Northern analysis suggested that Tino and KIAA2031 sequences do not correspond to the full-length mRNA, indicated by the size discrepancies between the expected and detected transcripts. In order to identify the 5' and 3' ends of the mRNA of Tino, we applied two different approaches: PCR-based 5'-and 3'-RACE and the gene prediction program GENSCAN. RACE analysis showed that the missing part Tino is a novel bcl-2 AU-rich element Binding Protein 24 of the transcript is the 5' end. The 3'-RACE product was completely overlapping with the terminal 3'UTR of Tino and KIAA2031. Through the GENSCAN analysis, we detected two RT-PCR products in HeLa and RPE cells (Fig. 7A) , extending by 198 and 159 nucleotides the 5' ends of Tino cDNAs. We believe these represent alternative splicing products. Their sequences were aligned within the corresponding genomic region and translated into protein. At the genomic level they form two short introns (Fig. 7B) . The splicing consensus boundaries are GC/CG for the longer and GA/CG for the shorter form. These acceptor and donor site pairs are neither canonical nor non-canonical splice sites, nevertheless we can not exclude the possibility that the transcripts derive from alternative splicing because of the presence of a branch site and pentamer (CTGCC) functioning as intronic splicing enhancer (35) . This kind of pentamer accurately identifies human short introns. It represents the major contribution to intron recognition when computational analyses are performed. At the protein level, the difference seems to be functionally sound.
Indeed, the two products codify proteins differing only at a particular phosphorylation site, whose consensus sequence is RXRXXS/T, which is the substrate of Protein Kinase B/Akt. This site, in the form RGRPGT, is present in the longer product (Fig. 7B) .
The antibody obtained with a peptide based method allows to detect three major bands in western blot, possibly corresponding to the endogenous pTino: a doublet of about 70 -75 kDa and one single band of about 39 kDa (Fig. 6C, lanes 3 and 6) . The lower band in the upper doublet appears to be unspecific because is clearly detected even when the antibody is blocked by the specific peptides (Fig.   6D) . The size of the specific upper band suggests the presence of an extra sequence with respect to the recombinant pTino. Bona fide the extra sequence corresponds to the unknown N-terminus of the novel protein, while the lower band derives probably from proteolytic processing yielding the band of about 39 kDa.
What is the functional significance of the physical association between pTino and the bcl-2 ARE? To address this question, we used an inducible β-globin reporter gene with the bcl-2 ARE linked to the Tino is a novel bcl-2 AU-rich element Binding Protein 25 by guest on http://www.jbc.org/ Downloaded from 3'UTR. Transient transfection of Tino significantly accelerated (2 fold) mRNA reporter decay when the 107mer ARE motif was present in the mRNA 3'UTR (Fig. 9) . Since the destabilizing protein AUF1 is another bcl-2 mRNA AUBP (16), we suppose that pTino is part of the mechanism of posttranscriptional control of bcl-2 expression and that probably acts "cooperatively" with AUF1 (Fig. 3A, 3B) . In particular, the pooling of the binding sites of Tino and AUF1 over 48 nucleotides of the bcl-2 ARE -where pTino partially shares its binding site with p40 AUF1 and is contiguous to the binding site of p37 AUF1 , while the latter completely overlaps the binding site of p40 AUF1 -suggests a strictly coordinated mode of action that could explain different outputs of bcl-2 expression in basal condition and during apoptosis. The ARE-based decay pathway is a cytoplasmic event, while the subcellular localization of the endogenous pTino we observed is mostly nuclear and perinuclear (Fig. 8) . Accordingly, we suspect that the bcl-2 mRNA destabilizing properties can be enhanced by pTino redistribution to the cytoplasm upon apoptosis.
One example of regulated ARE binding protein is furnished by CUGBP2 (CUG-Binding Protein 2), a multifunctional protein containing three nonidentical RRMs motifs that is capable of apolipoprotein B and COX-2 AU-rich sequence interaction. Interestingly, CUGBP2 is an highly conserved AU-rich element binding protein able to relocate from the nucleus to the cytoplasm following apoptotic stimuli, and thus able to repress COX-2 mRNA translation (36, 37) . Our future research on Tino will comprise to examine its functional participation in cellular life and death, both in physiological and pathological conditions, and to verify its cellular redistribution and transport pathway.
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